Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma <i>via</i> miR-876-3p.

Authors:
Kang SH; Oh SY; Lee KY; Lee HJ; Kim MS and 5 more

Journal:
Theranostics

Publication Year: 2024

DOI:
10.7150/thno.87329

PMCID:
PMC10758057

PMID:
38169528

Journal Information

Full Title: Theranostics

Abbreviation: Theranostics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the secretome antibody array data generated in this study are publicly available in gene expression omnibus (geo) at gse229247."

Code Sharing
Evidence found in paper:

"Competing Interests: The authors have declared that no competing interest exists."

Evidence found in paper:

"This work was supported by the Basic Science Research Program from the National Research Foundation (NRF) of Korea, funded by the Korean Government (MIST 2022R1A2C2006728, 2021R1A6A3A13038422), and in part by the ICT & Future Planning (2021R1A2C4002660). Author contributionsConceptualization: S-H H, S-Y C; Methodology: SHK, SYO, KYL; Investigation: SHK, KYL , M-S K, T-G K, H-J L, J-W K, S-T L; Visualization: S-H H, SYO, H-J L; Funding acquisition: S-H H, S-Y C; Project administration: SYO; Supervision: S-H H; Writing-original draft: S-H H, SHK, SYO, M-S K; Writing-review & editing: KYL, T-G K, H-J L, J-W K, S-T L, S-Y C."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025